ÇAĞLAR TUNCALI, M. Et Al. 2012. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer. NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.3 , 268-274.

ÇAĞLAR TUNCALI, M., Bozkurt, F. M., KAPULU AKÇA, C. D., Vargol, S. E., BAYRAKTAR, M., UĞUR, Ö., ... Karaagaoglu, E.(2012). Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer. NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.3, 268-274.

ÇAĞLAR TUNCALI, MELTEM Et Al. "Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer," NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.3, 268-274, 2012

ÇAĞLAR TUNCALI, MELTEM Ç. Et Al. "Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer." NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.3, pp.268-274, 2012

ÇAĞLAR TUNCALI, M. Et Al. (2012) . "Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer." NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.3, pp.268-274.

@article{article, author={MELTEM ÇAĞLAR TUNCALI Et Al. }, title={Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2012, pages={268-274} }